Clinical Efficacy of Zoledronic Acid on Fracture Reduction in Youth With Primary and Secondary Skeletal Fragility
ZA treatment as a component of clinical care was associated with significant declines in fracture rate in this cohort of children and young adults with skeletal fragility.
Authors
- Heather M. Monk (ORCID: https://orcid.org/0000-0002-6676-0833)
- Ashley J. Stoffers (ORCID: https://orcid.org/0000-0002-8058-9155)
- M. Mayer (ORCID: https://orcid.org/0000-0001-7600-0873)
- Michael A. Levine (ORCID: https://orcid.org/0000-0003-0036-7809)
- David R. Weber (ORCID: https://orcid.org/0000-0001-6895-2372)
- Joseph Rosano
- Edna E. Mancilla
Institutions
- Children's Hospital of Philadelphia (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1210/clinem/dgae661
- Primary Topic
- Bone health and osteoporosis research
- Type
- article
- Field-Weighted Citation Impact
- 0.00